ロード中...
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy. To treat the disease successfully, new therapeutic strategies are urgently needed. One of these strategies can be the use of neurokinin-1 receptor (NK-1R) antagonists (e.g., aprepitant), because the substance P (SP)/NK-1R syst...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2020-06-01
|
| シリーズ: | Journal of Clinical Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2077-0383/9/6/1659 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|